180 related articles for article (PubMed ID: 26856598)
1. Regulation of epithelial-mesenchymal transition in endometrial cancer: connecting PI3K, estrogen signaling, and microRNAs.
Kent CN; Guttilla Reed IK
Clin Transl Oncol; 2016 Nov; 18(11):1056-1061. PubMed ID: 26856598
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA‑195 inhibits epithelial‑mesenchymal transition by targeting G protein‑coupled estrogen receptor 1 in endometrial carcinoma.
Deng J; Wang W; Yu G; Ma X
Mol Med Rep; 2019 Nov; 20(5):4023-4032. PubMed ID: 31545414
[TBL] [Abstract][Full Text] [Related]
3. The impact of microRNA-mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer.
Dong P; Konno Y; Watari H; Hosaka M; Noguchi M; Sakuragi N
J Transl Med; 2014 Aug; 12():231. PubMed ID: 25141911
[TBL] [Abstract][Full Text] [Related]
4. A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition.
Xu W; Yang Z; Lu N
Cell Adh Migr; 2015; 9(4):317-24. PubMed ID: 26241004
[TBL] [Abstract][Full Text] [Related]
5. Tumor progression, metastasis, and modulators of epithelial-mesenchymal transition in endometrioid endometrial carcinoma: an update.
Makker A; Goel MM
Endocr Relat Cancer; 2016 Feb; 23(2):R85-R111. PubMed ID: 26538531
[TBL] [Abstract][Full Text] [Related]
6. Lack of estrogen receptor-α is associated with epithelial-mesenchymal transition and PI3K alterations in endometrial carcinoma.
Wik E; Ræder MB; Krakstad C; Trovik J; Birkeland E; Hoivik EA; Mjos S; Werner HM; Mannelqvist M; Stefansson IM; Oyan AM; Kalland KH; Akslen LA; Salvesen HB
Clin Cancer Res; 2013 Mar; 19(5):1094-105. PubMed ID: 23319822
[TBL] [Abstract][Full Text] [Related]
7. Autocrine motility factor promotes endometrial cancer progression by targeting GPER-1.
Li Y; Jia Y; Bian Y; Tong H; Qu J; Wang K; Wan XP
Cell Commun Signal; 2019 Mar; 17(1):22. PubMed ID: 30836961
[TBL] [Abstract][Full Text] [Related]
8. The EMT signaling pathways in endometrial carcinoma.
Colas E; Pedrola N; Devis L; Ertekin T; Campoy I; Martínez E; Llauradó M; Rigau M; Olivan M; Garcia M; Cabrera S; Gil-Moreno A; Xercavins J; Castellvi J; Garcia A; Ramon y Cajal S; Moreno-Bueno G; Dolcet X; Alameda F; Palacios J; Prat J; Doll A; Matias-Guiu X; Abal M; Reventos J
Clin Transl Oncol; 2012 Oct; 14(10):715-20. PubMed ID: 22911547
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
Xia H; Ooi LL; Hui KM
Hepatology; 2013 Aug; 58(2):629-41. PubMed ID: 23471579
[TBL] [Abstract][Full Text] [Related]
10. EFEMP1 is repressed by estrogen and inhibits the epithelial-mesenchymal transition via Wnt/β-catenin signaling in endometrial carcinoma.
Yang T; Zhang H; Qiu H; Li B; Wang J; Du G; Ren C; Wan X
Oncotarget; 2016 May; 7(18):25712-25. PubMed ID: 27015552
[TBL] [Abstract][Full Text] [Related]
11. Endometrial Carcinoma Recurrence Score (ECARS) validates to identify aggressive disease and associates with markers of epithelial-mesenchymal transition and PI3K alterations.
Wik E; Trovik J; Kusonmano K; Birkeland E; Raeder MB; Pashtan I; Hoivik EA; Krakstad C; Werner HM; Holst F; Mjøs S; Halle MK; Mannelqvist M; Mauland KK; Oyan AM; Stefansson IM; Petersen K; Simon R; Cherniack AD; Meyerson M; Kalland KH; Akslen LA; Salvesen HB
Gynecol Oncol; 2014 Sep; 134(3):599-606. PubMed ID: 24995579
[TBL] [Abstract][Full Text] [Related]
12. CCL20 mediates RANK/RANKL-induced epithelial-mesenchymal transition in endometrial cancer cells.
Liu Y; Wang J; Ni T; Wang L; Wang Y; Sun X
Oncotarget; 2016 May; 7(18):25328-39. PubMed ID: 27015366
[TBL] [Abstract][Full Text] [Related]
13. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z
Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096
[TBL] [Abstract][Full Text] [Related]
14. Suppression of the epithelial-mesenchymal transition by SHARP1 is linked to the NOTCH1 signaling pathway in metastasis of endometrial cancer.
Liao Y; He X; Qiu H; Che Q; Wang F; Lu W; Chen Z; Qiu M; Wang J; Wang H; Wan X
BMC Cancer; 2014 Jul; 14():487. PubMed ID: 24997474
[TBL] [Abstract][Full Text] [Related]
15. miR-205 promotes epithelial-mesenchymal transition by targeting AKT signaling in endometrial cancer cells.
Jin C; Liang R
J Obstet Gynaecol Res; 2015 Oct; 41(10):1653-60. PubMed ID: 26446417
[TBL] [Abstract][Full Text] [Related]
16. Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cells.
McCubrey JA; Fitzgerald TL; Yang LV; Lertpiriyapong K; Steelman LS; Abrams SL; Montalto G; Cervello M; Neri LM; Cocco L; Martelli AM; Laidler P; Dulińska-Litewka J; Rakus D; Gizak A; Nicoletti F; Falzone L; Candido S; Libra M
Oncotarget; 2017 Feb; 8(8):14221-14250. PubMed ID: 27999207
[TBL] [Abstract][Full Text] [Related]
17. Epithelial-to-mesenchymal transition rewires the molecular path to PI3K-dependent proliferation.
Salt MB; Bandyopadhyay S; McCormick F
Cancer Discov; 2014 Feb; 4(2):186-99. PubMed ID: 24302555
[TBL] [Abstract][Full Text] [Related]
18. Soluble epoxide hydrolase inhibition ameliorates proteinuria-induced epithelial-mesenchymal transition by regulating the PI3K-Akt-GSK-3β signaling pathway.
Liang Y; Jing Z; Deng H; Li Z; Zhuang Z; Wang S; Wang Y
Biochem Biophys Res Commun; 2015 Jul 17-24; 463(1-2):70-5. PubMed ID: 25986738
[TBL] [Abstract][Full Text] [Related]
19. TET1-GPER-PI3K/AKT pathway is involved in insulin-driven endometrial cancer cell proliferation.
Xie BY; Lv QY; Ning CC; Yang BY; Shan WW; Cheng YL; Gu C; Luo XZ; Zhang ZB; Chen XJ; Xi XW; Feng YJ
Biochem Biophys Res Commun; 2017 Jan; 482(4):857-862. PubMed ID: 27889612
[TBL] [Abstract][Full Text] [Related]
20. miR‑215 promotes epithelial to mesenchymal transition and proliferation by regulating LEFTY2 in endometrial cancer.
Gao X; Cai Y; An R
Int J Mol Med; 2018 Sep; 42(3):1229-1236. PubMed ID: 29845221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
